NCT06204302 - An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States | Biotech Hunter

Enrollment

1,800

Participants

Timeline

Start Date

January 5, 2024

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions

Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer

Interventions

DRUG

Darolutamide (Nubeqa, BAY1841788)

Retrospective cohort analysis, using Komodo Research Database (KRD)

DRUG

Enzalutamide

Retrospective cohort analysis, using Komodo Research Database (KRD)

DRUG

Apalutamide

Retrospective cohort analysis, using Komodo Research Database (KRD)

Trial Locations (1)

Bayer, Whippany